These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 6279288)

  • 21. The effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721) on intestinal crypt survival. I. 4 MeV x-rays.
    Sigdestad CP; Connor AM; Scott RM
    Radiat Res; 1975 May; 62(2):267-75. PubMed ID: 1124278
    [No Abstract]   [Full Text] [Related]  

  • 22. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
    Green D; Bensely D; Schein P
    Cancer Res; 1994 Feb; 54(3):738-41. PubMed ID: 8306335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of mice against fission neutron irradiation by WR-2721 or WR-151327.
    Steel LK; Jacobs AJ; Giambarresi LI; Jackson WE
    Radiat Res; 1987 Mar; 109(3):469-78. PubMed ID: 3031721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of radiation induced damage in mouse intestine by WR-2721.
    Bisht KS; Prabhu S; Devi PU
    Indian J Exp Biol; 2000 Jul; 38(7):669-74. PubMed ID: 11215309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine.
    Yuhas JM
    Cancer Treat Rep; 1979 Jun; 63(6):971-6. PubMed ID: 223759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimutagenic effects of amifostine: clinical implications.
    Kataoka Y; Perrin J; Hunter N; Milas L; Grdina DJ
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):53-7. PubMed ID: 8783668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine.
    Paunesku D; Paunesku T; Wahl A; Kataoka Y; Murley J; Grdina DJ; Woloschak GE
    Int J Radiat Biol; 2008 Aug; 84(8):623-34. PubMed ID: 18661379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR 2721) on intestinal crypt survival. II. Fission neutrons.
    Sigdestad CP; Connor AM; Scott RM
    Radiat Res; 1976 Mar; 65(3):430-9. PubMed ID: 1265205
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of radioprotection from three neutron sources and 60Co by WR-2721 and WR-151327.
    Sigdestad CP; Grdina DJ; Connor AM; Hanson WR
    Radiat Res; 1986 May; 106(2):224-33. PubMed ID: 3010368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioprotection of mouse colony forming units-spleen against heavy-charged particle damage by WR 2721.
    Afzal SM; Ainsworth EJ
    Radiat Res; 1987 Jan; 109(1):118-26. PubMed ID: 3027738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leech salivary gland extract from Haementeria officinalis, a potent inhibitor of cyclophosphamide- and radiation-induced artificial metastasis enhancement.
    Gasic GJ; Iwakawa A; Gasic TB; Viner ED; Milas L
    Cancer Res; 1984 Dec; 44(12 Pt 1):5670-6. PubMed ID: 6498828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of reduction in the testicular weight by WR-2721 in relation to the body weight after whole-body gamma irradiation.
    Bhartiya HC; Jaimala
    Strahlenther Onkol; 1986 Jan; 162(1):68-70. PubMed ID: 3003944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation protection of murine intestine by WR-2721, 16,16-dimethyl prostaglandin E2, and the combination of both agents.
    Hanson WR
    Radiat Res; 1987 Aug; 111(2):361-73. PubMed ID: 2819937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of spermatogonial survival and testicular function by WR-2721 against high and low doses of radiation.
    Meistrich ML; Finch MV; Hunter N; Milas L
    Int J Radiat Oncol Biol Phys; 1984 Nov; 10(11):2099-107. PubMed ID: 6092308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721.
    Wasserman TH; Phillips TL; Ross G; Kane LJ
    Cancer Clin Trials; 1981; 4(1):3-6. PubMed ID: 6260393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticlastogenic effect of S-2-(3-aminopropylamino) ethylphosphorothioic acid against X-rays in mice.
    Mazur L
    Physiol Res; 1996; 45(1):59-63. PubMed ID: 8884925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promotion of cystine uptake, increase of glutathione biosynthesis, and modulation of glutathione status by S-2-(3-aminopropylamino)ethyl phosphorothioic acid (WR-2721) in Chinese hamster cells.
    Issels RD; Nagele A
    Cancer Res; 1989 Apr; 49(8):2082-6. PubMed ID: 2539252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale for initial clinical trials and future development of radioprotectors.
    Phillips TL
    Cancer Clin Trials; 1980; 3(2):165-73. PubMed ID: 6253097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous basic fibroblast growth factor protects the lung but not mediastinal organs against radiation-induced apoptosis in vivo.
    Fuks Z; Alfieri A; Haimovitz-Friedman A; Seddon A; Cordon-Cardo C
    Cancer J Sci Am; 1995; 1(1):62-72. PubMed ID: 9166456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors.
    Milas L; Hersh EM; Stringfellow DA; Hunter N
    J Natl Cancer Inst; 1982 Jan; 68(1):139-45. PubMed ID: 6172625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.